Green Thumb Industries Inc. (OTC:GTBIF – Free Report) – Equities researchers at Roth Capital upped their Q2 2025 earnings estimates for shares of Green Thumb Industries in a report issued on Tuesday, August 6th. Roth Capital analyst S. Fortune now anticipates that the company will post earnings per share of $0.11 for the quarter, up from their previous estimate of $0.07.
Separately, Ventum Cap Mkts raised shares of Green Thumb Industries to a “strong-buy” rating in a report on Tuesday.
Green Thumb Industries Stock Down 4.3 %
GTBIF traded down $0.51 during mid-day trading on Wednesday, reaching $11.25. 268,427 shares of the stock were exchanged, compared to its average volume of 507,464. Green Thumb Industries has a 1 year low of $6.42 and a 1 year high of $16.33.
Green Thumb Industries Company Profile
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.
Featured Stories
- Five stocks we like better than Green Thumb Industries
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- The Cannabis Sector: Profitability Takes Center Stage
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- What is the S&P/TSX Index?
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.
